Literature DB >> 11929051

Functional studies of mutations in the human protoporphyrinogen oxidase gene in variegate porphyria.

Rhian R Morgan1, Silva Vasco da, Hervé Puy, Jean-Charles Deybach, George H Elder.   

Abstract

The autosomal dominant disorder, variegate porphyria (VP), results from mutations in the protoporphyrinogen oxidase (PPOX) gene. We have investigated the effects of 22 disease-associated missense mutations in this gene on enzyme activity. Mutants were generated in the expression plasmid pHPPOX by site-directed mutagenesis. They were screened for PPOX activity by complementation of the Escherischia coli strain SAS38X which lacks PPOX activity. Ten mutants (G40E, L85P, G232R, de1281H, V282D, L295P, V335G, S350P, L444P, G453V) had no detectable PPOX activity. PPOX activity of the remaining 12 mutants (L15F, R38P, L73P, V84G, D143V, R152C, L154P, V158M, R168H, A172V, V290L, G453R) ranged from less than 1% to 9.2% of wild-type activity. Our findings show that all 22 mutations substantially impair or abolish PPOX activity in a prokaryotic expression system and add to the evidence that they cause VP.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11929051

Source DB:  PubMed          Journal:  Cell Mol Biol (Noisy-le-grand)        ISSN: 0145-5680            Impact factor:   1.770


  3 in total

1.  Randomised by (your) god: robust inference from an observational study design.

Authors:  George Davey Smith
Journal:  J Epidemiol Community Health       Date:  2006-05       Impact factor: 3.710

2.  Identification of sequences required for the import of human protoporphyrinogen oxidase to mitochondria.

Authors:  Rhian R Morgan; Rachel Errington; George H Elder
Journal:  Biochem J       Date:  2004-01-15       Impact factor: 3.857

3.  Characterisation of the flavin adenine dinucleotide binding region of Myxococcus xanthus protoporphyrinogen oxidase.

Authors:  Mavis O Boateng; Anne V Corrigall; Edward Sturrock; Peter N Meissner
Journal:  Biochem Biophys Rep       Date:  2015-10-29
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.